REVVITY, INC Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount
REVVITY, INC (RVTY) reported Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount of -$4.60 million for the 12-month period ending 2025-12-28, per its 10-K filed 2026-02-24.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Components of Deferred Tax Assets
us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount · last filed 2026-02-24
- REVVITY, INC valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2025 was -$4.60M, a 115.44% decline from fiscal 2024.
- REVVITY, INC valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2024 was $29.80M.
- REVVITY, INC valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2023 was -$7.20M, a 187.80% decline from fiscal 2022.
- REVVITY, INC valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2022 was $8.20M.
| Period end | Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount 12 month |
|---|---|
| 2025-12-28 | -$4.60M 10-K · filed 2026-02-24 |
| 2024-12-29 | $29.80M 10-K · filed 2025-02-25 |
| 2023-01-01 | -$7.20M 10-K · filed 2023-03-01 |
| 2022-01-02 | $8.20M 10-K · filed 2022-03-03 |
| 2021-01-03 | -$11.30M 10-K · filed 2021-03-02 |
| 2019-12-29 | $13.60M 10-K · filed 2020-02-25 |
| 2018-12-30 | -$33.20M 10-K · filed 2019-02-26 |
| 2017-12-31 | -$3.30M 10-K · filed 2018-02-27 |
| 2016-01-03 | -$11.90M 10-K · filed 2017-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Avantor, Inc. (AVTR) | United States | $10.501B | -9.72 |
| BRUKER CORP (BRKR) | United States | $9.706B | -128.75 |
| METTLER TOLEDO INTERNATIONAL INC/ (MTD) | $30.436B | 30.62 | |
| Alamar Biosciences, Inc. (ALMR) | United States | $2.300B | |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |